Trends in mortality attributed to asthma in the 5-34-year age group were examined in New Zealand, Australia, England and Wales, the United States, Canada, and West Germany for the years 1959-79. An epidemic of deaths from asthma occurred in the mid-1960s in New Zealand, Australia, and England and Wales but not in the other countries. In Australia and England and Wales the death rate quickly returned to pre-epidemic levels, but in New Zealand the decline in mortality was slow, and by 1974 the death rate was still almost double the pre-epidemic level. Of great concern was an abrupt increase in reported deaths from asthma in New Zealand after 1976 with the mortality rate during 1977-9 being greater than during the previous epidemic. In contrast, asthma mortality had remained relatively stable in the other populations.The new epidemic in New Zealand was investigated and appeared to be real. It could not be explained by changes in the classification of deaths from asthma, inaccuracies in death certification, or changes in diagnostic fashions. The most likely explanation appeared to be related to the management of asthma in New Zealand, and this is being investigated.
Deaths from asthma in Italy (1974-1988): is there a relationship with changing pharmacological approaches?
International trends in sales of inhaled fenoterol, all inhaled beta-agonists, and asthma mortality, 1970-1992
Demographic characteristics of patients experiencing near-fatal and fatal asthma: results of a regional survey of 400 asthma specialists [see comment
Has the prevalence of asthma increased in children? Evidence from the national study of health and growth 1973-86
Changes in hospital management of acute severe asthma by thoracic and general physicians in Birmingham and Manchester during 1978 and 1985
Why are hospital admission and mortality rates for childhood asthma higher in New Zealand than in the United Kingdom?
Demographic characteristics of patients with severe life threatening asthma: comparison with asthma deaths
Major reduction in asthma morbidity and continued reduction in asthma mortality in New Zealand: what lessons have been learned?
Effects of sequential doses of parenteral terbutaline on plasma levels of potassium and related cardiopulmonary responses
Comparison of bronchial reactivity and peak expiratory flow variability measurements for epidemiologic studies
Long-term prognosis of near-fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma
An update on the safety of long-acting beta-agonists in asthma patients using inhaled corticosteroids
Age- and gender-specific asthma death rates in patients taking long-acting beta2-agonists: prescription event monitoring pharmacosurveillance studies
Drug-induced left ventricular failure in patients with pulmonary disease. Endomyocardial biopsy demonstration of catecholamine myocarditis
International trends in asthma mortality rates in the 5- to 34-year age group: a call for closer surveillance
The diagnosis of potentially fatal asthma in hospitalized adults. Patient characteristics and increased severity of asthma
Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma
Prevalence and treatment of asthma in the Michigan Medicaid patient population younger than 45 years, 1980-1986
Adverse effects and complications of treatment with beta-adrenergic agonist drugs. Committee on drugs, the American Academy of Allergy and Immunology
Allergen-specific IgE levels and mite allergen exposure in children with acute asthma first seen in an emergency department and in nonasthmatic control subjects
Clinical complexity and epidemiologic uncertainty in case-control research. Fenoterol and asthma management
Total and free thyroid hormone concentrations in patients receiving replacement treatment with thyroxine
Analysis of the Indacaterol-Regulated Transcriptome in Human Airway Epithelial Cells Implicates Gene Expression Changes in the Adverse and Therapeutic Effects of β2 -Adrenoceptor Agonists
Albuterol: an adrenergic agent for use in the treatment of asthma pharmacology, pharmacokinetics and clinical use
This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.
Allergy and Asthma
Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.